MASHINIi

Anbio Biotechnology.

NNNN.US | Manufacture of medical and dental instruments and supplies

Anbio Biotechnology Co., Ltd. focuses on the research, development, manufacture, and marketing of in-vitro diagnostic (IVD) products. The company offers a range of IVD solutions, including immunoassay, molecular diagnostics, and point-of-care testing (POCT) products. These products are used for the ...Show More

Ethical Profile

Mixed.

Not enough information to create an ethical profile.

Value Scores

Better Health for All0
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect0
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business0
-100100
Kind to Animals0
-100100
No War, No Weapons0
-100100
Planet-Friendly Business0
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech-30
-100100
Zero Waste & Sustainable Products0
-100100

Better Health for All

0

No evidence available to assess Anbio Biotechnology on Better Health for All.

Fair Money & Economic Opportunity

0

No evidence available to assess Anbio Biotechnology on Fair Money & Economic Opportunity.

Fair Pay & Worker Respect

0

The provided articles do not contain specific, quantitative data for NNNN.US (Anbio Biotechnology) for any of the KPIs under Fair Pay & Worker Respect. While outlines general commitments to treating employees with dignity and respect, providing equal employment opportunities, and complying with health and safety laws,

1
these are policy statements and do not provide measurable outcomes or specific figures required by the rubric's quantitative thresholds. Other articles provide general industry data or benchmarks, but no information directly attributable to NNNN.US.

Fair Trade & Ethical Sourcing

0

No evidence available to assess Anbio Biotechnology on Fair Trade & Ethical Sourcing.

Honest & Fair Business

0

No specific, concrete evidence was found in the provided articles to assess Anbio Biotechnology against any of the 'Honest & Fair Business' KPIs. The articles explicitly state that information regarding regulatory fines, transparency index scores, whistleblower policies, financial restatements, audit coverage, ESG controversy scores, complaint resolution times, board conflict-free percentages, anti-corruption policies, and third-party verification is not available or present.

1

Kind to Animals

0

No explicit evidence was found regarding Anbio Biotechnology's cruelty-free certifications, use of alternative testing methods for product safety and efficacy, humane certifications for operations, wildlife conservation impact, ethical input substitution, supplier audit practices for animal welfare, cage-free sourcing, animal testing policy, animal testing volume, innovation investment in animal-free technologies, animal agriculture ethics, animal-free R&D collaboration, or public policy engagement related to animal welfare.

1
Mentions of veterinary diagnostics and molecular diagnostic systems do not explicitly state their role in replacing animal testing for product safety or efficacy, nor do they provide details on the company's animal welfare practices or policies.
2

No War, No Weapons

0

No evidence available to assess Anbio Biotechnology on No War, No Weapons.

Planet-Friendly Business

0

No evidence available to assess Anbio Biotechnology on Planet-Friendly Business.

Respect for Cultures & Communities

0

No specific, concrete data points were found in the provided articles for any of the KPIs related to 'Respect for Cultures & Communities'. The articles primarily focus on Anbio Biotechnology's participation in industry conferences, product registrations in over 100 countries, and the number of test items supported by its systems.

1
There is no information regarding formal partnerships with community groups, reinvestment in local development, cultural appropriation incidents, impact assessment protocols, local employment, grievance mechanisms, or any other community-related metrics.
2

Safe & Smart Tech

-30

Anbio Biotechnology allows users to unsubscribe from communications at any time.

1
This represents a basic data control option with significant limitations as it does not specify broader control over personal data or privacy settings. The company includes cybersecurity risk management and strategy disclosures in its 20-F Annual Report
2
and has filed various forms related to Securities Exchange Act rules 13a-16 and 15d-16, and Section 12(b) or (g),
3
indicating basic compliance with applicable regulations.

Zero Waste & Sustainable Products

0

No evidence available to assess Anbio Biotechnology on Zero Waste & Sustainable Products.

Own Anbio Biotechnology?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.